These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Effect of interferon on transcription and translation of vesicular stomatitis virus in human and simian cell cultures. Thacore HR. J Gen Virol; 1978 Nov; 41(2):421-6. PubMed ID: 214523 [Abstract] [Full Text] [Related]
28. Different antiviral activity and cell specificity of interferon preparations produced by mouse peritoneal cells at 37 degrees C and at 26 degrees C. Cembrzyńska-Nowak M. Arch Immunol Ther Exp (Warsz); 1989 Nov; 37(5-6):499-502. PubMed ID: 2484831 [Abstract] [Full Text] [Related]
29. Brefeldin A blocks protein glycosylation and RNA replication of vesicular stomatitis virus. Irurzun A, Pérez L, Carrasco L. FEBS Lett; 1993 Dec 28; 336(3):496-500. PubMed ID: 8282118 [Abstract] [Full Text] [Related]
30. Evaluation of cytotoxicity and antiviral activity of recombinant human interferon alfa-2a and recombinant human interferon alfa-B/D hybrid against bovine viral diarrhea virus, infectious bovine rhinotracheitis virus, and vesicular stomatitis virus in vitro. Peek SF, Bonds MD, Gangemi DG, Thomas CB, Schultz RD. Am J Vet Res; 2004 Jun 28; 65(6):871-4. PubMed ID: 15198231 [Abstract] [Full Text] [Related]
31. Synergistic anticellular and antiviral activities of human recombinant interferon-gamma and -beta. Gomi K, Kimura H, Okabe M, Oka T, Morimoto M. J Pharmacobiodyn; 1986 Nov 28; 9(11):871-8. PubMed ID: 3031263 [Abstract] [Full Text] [Related]
33. Mechanism of interferon action: inhibition of vesicular stomatitis virus replication in human amnion U cells by cloned human leukocyte interferon. I. Effect on early and late stages of the viral multiplication cycle. Masters PS, Samuel CE. J Biol Chem; 1983 Oct 10; 258(19):12019-25. PubMed ID: 6311834 [Abstract] [Full Text] [Related]
35. In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD). Zhang XM, He DN, Zhou B, Pang R, Liu K, Zhao J, Chen PY. Antiviral Res; 2013 Aug 10; 99(2):149-57. PubMed ID: 23727591 [Abstract] [Full Text] [Related]
37. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection. Trottier MD, Palian BM, Reiss CS. Virology; 2005 Mar 15; 333(2):215-25. PubMed ID: 15721356 [Abstract] [Full Text] [Related]
38. Use of Brefeldin A to localize block in intracellular transport of vesicular stomatitis virus G protein on interferon-treated cells. Polakova K, Russ G. Arch Virol; 1992 Mar 15; 124(1-2):171-9. PubMed ID: 1373940 [Abstract] [Full Text] [Related]
39. Establishing a safe, rapid, convenient and low-cost antiviral assay of interferon bioactivity based on recombinant VSV expressing GFP. Chen W, Wen Z, Zhang J, Li C, Huang K, Bu Z. J Virol Methods; 2018 Feb 15; 252():1-7. PubMed ID: 28834736 [Abstract] [Full Text] [Related]
40. Inhibition of vesicular stomatitis virus replication by epidermal growth factor in human epidermoid A-431 cells. Korutla L, Kumar R. Biochem Biophys Res Commun; 1996 Mar 27; 220(3):670-4. PubMed ID: 8607823 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]